VHL and von Hippel-Lindau disease: As the new medications for VHL continue to expand the potential therapeutic options for VHL patients, increased reporting of therapeutic responses and adverse effects in VHL patients will help guide medical and/or surgical management decisions in VHL patients with more complex medical histories.